Literature DB >> 29488230

Molecular epidemiology of rotavirus gastroenteritis in Japan during 2014-2015: Characterization of re-emerging G2P[4] after rotavirus vaccine introduction.

Nusrat Khandoker1, Aksara Thongprachum1,2, Sayaka Takanashi1, Shoko Okitsu1,2, Shuichi Nishimura2, Hideaki Kikuta2, Atsuko Yamamoto2, Kumiko Sugita2, Tsuneyoshi Baba2, Masaaki Kobayashi2, Satoshi Hayakawa2, Masashi Mizuguchi1, Hiroshi Ushijima1,2.   

Abstract

Rotavirus vaccines have been available in Japan since 2011. This study conducted to monitor the trend of group A rotavirus (RVA) genotypes 3 years after vaccine introduction. A total of, 539 fecal samples were collected from children with acute gastroenteritis in six regions during July 2014-June 2015. Among them, 178 samples (33.0%) were positive for RVA. The most predominant genotype was G1P[8] (35.9%) followed by G2P[4] (26.4%), G9P[8] (21.3%), G3P[8] (4.5%), and G3P[9] (4.5%). The detection rate of G2P[4] was increased soon after vaccine introduction. Sequence analyses of VP7 and VP4 genes of the representative G2P[4] strains were found to be clustered in sub-lineage IVa of lineage IV. It is noteworthy that one amino acid substitution in the antigenic epitope (Q114P) of VP4 gene was found in representative G2P[4] strains of the current study. However, it is unclear whether the change in antigenic epitope is due to the effect of vaccination or due to natural variation, warranting further continuous monitoring of rotavirus evolution after vaccine introduction.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  antigenic epitope; rotavirus; sequence analyses; vaccination

Mesh:

Substances:

Year:  2018        PMID: 29488230     DOI: 10.1002/jmv.25067

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Longitudinal surveillance of rotavirus A genotypes circulating in a high milk yield dairy cattle herd after the introduction of a rotavirus vaccine.

Authors:  Juliana T T Fritzen; Marcos V Oliveira; Elis Lorenzetti; Flávia M Miyabe; Mariana P Viziack; Carlos A Rodrigues; Henderson Ayres; Alice F Alfieri; Amauri A Alfieri
Journal:  Vet Microbiol       Date:  2019-02-18       Impact factor: 3.293

2.  Evolutionary changes between pre- and post-vaccine South African group A G2P[4] rotavirus strains, 2003-2017.

Authors:  Peter N Mwangi; Nicola A Page; Mapaseka L Seheri; M Jeffrey Mphahlele; Sandrama Nadan; Mathew D Esona; Benjamin Kumwenda; Arox W Kamng'ona; Celeste M Donato; Duncan A Steele; Valantine N Ndze; Francis E Dennis; Khuzwayo C Jere; Martin M Nyaga
Journal:  Microb Genom       Date:  2022-04

3.  Prevalence and genotypes of group A rotavirus among outpatient children under five years old with diarrhea in Beijing, China, 2011-2016.

Authors:  Yi Tian; Abrar Ahmad Chughtai; Zhiyong Gao; Hanqiu Yan; Yanwei Chen; Baiwei Liu; Da Huo; Lei Jia; Quanyi Wang; Chandini Raina MacIntyre
Journal:  BMC Infect Dis       Date:  2018-10-03       Impact factor: 3.090

4.  Immunogenicity and safety of porcine circovirus-free human rotavirus vaccine in healthy infants: a phase III, randomized trial.

Authors:  Ignacio Salamanca de la Cueva; Barbara Pahud; Li-Min Huang; Michael Leonardi; José Garcia-Sicilia; Javier Céspedes; Arturo Abdelnour; Tsuyoshi Tamura; Haruo Kuroki; Nan-Chang Chiu; Miia Virta; Satu Kokko; Michael Horn; Falko Panzer; Jong-Hyun Kim; Lee Jin; Leentje Moerman; Christophe Debacq; Jose Parra; Ana Ugarte; Dan Bi
Journal:  J Infect Dis       Date:  2020-05-04       Impact factor: 7.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.